Takeda launches Fomepizole Intravenous Infusion 1.5g in Japan
Fomepizole , an alcohol dehydrogenase inhibitor , is marketed and distributed by Paladin Labs Inc. ( "Paladin" ) in Canada and is the standard treatment for ethylene glycol
The US Food and Drug Administration (FDA) has approved an expanded indication for Eli Lilly and Company’s Jaypirca (pirtobrutinib) as a first-line treatment for adults with previously untreated chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) who do not have a 17p deletion.
CRN, the leading trade association for the dietary supplement and functional food industry, developed these guidelines in response to recommendations from authoritative medical organizations, including the American Academy
Together with the National Institute of Allergy and Infectious Diseases (NIAID), WCCT-Global is currently conducting influenza infection studies in healthy volunteers and is the first CRO to conduct
The randomized double-blind, event-driven superiority trial is designed to examine the benefits of the once-daily, oral Factor Xa Inhibitor, rivaroxaban in these patients. Around 7,000 patients will be